Speaker

Prof. Tawesak Tanwandee

Professor of Gastroenterology
Head, Division of Gastroenterology, Department of Medicine,
Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand

Moderator

Tan Swee Jin, PhD, PMP
Senior Manager, Scientific Affairs, Sysmex Asia Pacific

Lecture Abstract

Chronic hepatitis B (CHB) is a global health challenge that requires an effective care pathway covering diagnosis, antiviral therapy, and monitoring to prevent disease progression and liver cancer. Non-invasive markers aid in prediction and reduce reliance on invasive procedures. The simplified treatment algorithm involves initial assessments and prioritising antiviral therapy, typically using affordable nucleos(t)ide analogs (NAs) for patients with significant fibrosis or cirrhosis. Integrating non-invasive markers improves early detection, simplifies treatment, and reduces the burden of CHB and its complications.

Join us for a webinar featuring Prof. Tawesak Tanwandee, an esteemed expert in hepatology, as we discuss optimising care pathways for chronic hepatitis B (CHB).

We hoped you have enjoyed the webinar and gained new insights!

May we request your time for a short survey?